- Links to sites outside of this website are provided as a resource to the viewer. bluebird bio accepts no responsibility for the content of linked sites.
- Baird analistleri, bluebird bio (BLUE) için Outperform notunu ve 6,00$ hedef fiyatını yineledi.Analistler şu yorumda bulundu...
- Hisse senedi fiyat hareketlerini izlemek için canlı bluebird bio, Inc. grafiğini görüntüleyin.
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States.
- bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders.
- Discover real-time bluebird bio, Inc. Common Stock (BLUE) stock prices, quotes, historical data, news, and Insights for informed trading and investment...
- Shares of Bluebird Bio Inc. soared 71.8% in premarket trading on Monday, days after a Food and Drug Administration advisory committee voted in favor of two of...
- bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days.
- bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases.
- We believe that the stock price of bluebird bio (NASDAQ: BLUE), a biotechnology company focused on gene therapies for severe genetic disorders and...
- With 15 patients started across its three gene therapies, bluebird bio claims a 138% year-over-year revenue growth and aims to initiate up to around 100 new...
- bluebird bio, Inc. (NASDAQ:BLUE) today announced that members of the management team will participate in fireside chats at the following upcoming investor...
- bluebird bio (BLUE) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom...
